Does Rallies show 13F holders for LAB?

Yes. Rallies tracks hedge fund and 13F ownership data for LAB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is LAB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LAB. It does not provide personalized investment advice.

LAB (Standard BioTools Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Standard BioTools Inc. Common Stock (LAB) is a publicly traded Healthcare sector company. As of May 21, 2026, LAB trades at $1.06 with a market cap of $386.11M and a P/E ratio of -5.13. LAB moved +5.00% today. Year to date, LAB is -19.70%; over the trailing twelve months it is +0.95%. Its 52-week range spans $0.87 to $2.32. Analyst consensus is neutral with an average price target of $1.35. Rallies surfaces LAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns LAB stock?

Hedge funds tracked by Rallies that own LAB include Viking Global, Redmile Group, and Corvex Management. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Standard BioTools Inc. Common Stock.

LAB Key Metrics

Key financial metrics for LAB
Metric	Value
Price	$1.06
Market Cap	$386.11M
P/E Ratio	-5.13
EPS	$-0.20
Dividend Yield	0.00%
52-Week High	$2.32
52-Week Low	$0.87
Volume	1.28M
Avg Volume	0
Revenue (TTM)	$85.33M
Net Income	$-74.90M
Gross Margin	49.86%

Top Hedge Funds Holding LAB

Viking Global holds 58.65M shares of LAB, changed +0.00% as of Mar 31, 2026.
Redmile Group holds 411.63K shares of LAB, changed +0.00% as of Jun 30, 2024.
Corvex Management holds 44.34K shares of LAB, changed -0.14% as of Mar 31, 2026.

Latest LAB News

Standard BioTools Q1 revenue rises 5% to $21.1M; adjusted EBITDA loss shrinks 78% — May 5, 2026
Standard BioTools Posts Q4 Revenue of $23.8M, Activates $40M Savings, Holds $550M Cash — Feb 24, 2026

Recent LAB Insider Trades

Casdin Partners Master Fund, L.P. bought 150.00K (~$217.02K) on Dec 4, 2025.
Casdin Partners Master Fund, L.P. bought 75.00K (~$108.04K) on Dec 3, 2025.
Casdin Partners Master Fund, L.P. bought 125.00K (~$177.51K) on Dec 2, 2025.

LAB Analyst Consensus

2 analysts cover LAB: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.35.

Common questions about LAB

Who owns LAB stock?: Hedge funds tracked by Rallies that own LAB include Viking Global, Redmile Group, and Corvex Management. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Standard BioTools Inc. Common Stock.
Does Rallies show 13F holders for LAB?: Yes. Rallies tracks hedge fund and 13F ownership data for LAB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is LAB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LAB. It does not provide personalized investment advice.